Nafas Journal

Abstract

Coronavirus disease has quickly become a serious concern in the international community due to its high unbelievable incidence and mortality. Meanwhile, treatment management in special groups, including pregnant and lactating women, faced serious challenges. Due to the numerous benefits of breastfeeding and the irreversible damages of ceasing breastfeeding in affected mothers, limited clinical studies have been performed on the possibility of protecting breastfeeding in mothers under remdesivir. The only effective drug approved by the US Food and Drug Administration in emergency situations is Remdesivir. There is not much information about the secretion of this drug in breast milk. In this letter, we mentioned breastfeeding can be continued in mothers treated with remdesivir; however, close monitoring of the infant is recommended